Paper28049044
Lymphocytes contribute to biliary injury and fibrosis in experimental xenobiotic-induced cholestasis.
Joshi N and 3 others. Toxicology, 2017. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Lymphocytes contribute to biliary injury and fibrosis in experimental xenobiotic-induced cholestasis. Papers, record 28049044. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28049044
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Lymphocytes contribute to biliary injury and fibrosis in experimental xenobiotic-induced cholestasis.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bile Ducts | Major topic |
| Cholestasis | Major topic |
| Liver Cirrhosis | Major topic |
| Lymphocytes | Major topic |
| Xenobiotics | Major topic |
| Animals | |
| Male | |
| Mice | |
| Mice, Inbred C57BL | |
| Mice, Knockout |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 ES017537 | NIEHS NIH HHS | United States | R01ES017537 | PubMed and NIH |
Source NIH RePORTER
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25869391 | ACG Clinical Guideline: Primary Sclerosing Cholangitis. | Am J Gastroenterol | 2015 | https://conductscience.org/library/papers/25869391 | PubMed |
| 2 | 27060337 | Role of hemostatic factors in hepatic injury and disease: animal models de-liver. | J Thromb Haemost | 2016 | https://conductscience.org/library/papers/27060337 | PubMed |
| 3 | 27605088 | Dose-dependent effects of alpha-naphthylisothiocyanate disconnect biliary fibrosis from hepatocellular necrosis. | J Biochem Mol Toxicol | 2017 | https://conductscience.org/library/papers/27605088 | PubMed |
| 4 | 23810223 | Primary sclerosing cholangitis. | Lancet | 2013 | https://conductscience.org/library/papers/23810223 | PubMed |
| 5 | 21356363 | Fibrinogen deficiency increases liver injury and early growth response-1 (Egr-1) expression in a model of chronic xenobiotic-induced cholestasis. | Am J Pathol | 2011 | https://conductscience.org/library/papers/21356363 | PubMed |
| 6 | 21037076 | The coagulation system contributes to alphaVbeta6 integrin expression and liver fibrosis induced by cholestasis. | Am J Pathol | 2010 | https://conductscience.org/library/papers/21037076 | PubMed |
| 7 | 5866807 | The nature of alpha-naphthylisothiocyanate-induced cholestasis. | Toxicol Appl Pharmacol | 1965 | https://conductscience.org/library/papers/5866807 | PubMed |
| 8 | 22094456 | Early growth response factor-1 limits biliary fibrosis in a model of xenobiotic-induced cholestasis in mice. | Toxicol Sci | 2012 | https://conductscience.org/library/papers/22094456 | PubMed |
| 9 | 17200187 | Alphav beta6 integrin regulates renal fibrosis and inflammation in Alport mouse. | Am J Pathol | 2007 | https://conductscience.org/library/papers/17200187 | PubMed |
| 10 | 15085484 | The pathology of cholestasis. | Semin Liver Dis | 2004 | https://conductscience.org/library/papers/15085484 | PubMed |
| 11 | 10655247 | Progressive development of a Th1-type hepatic cytokine profile in rats with experimental cholangitis. | Hepatology | 2000 | https://conductscience.org/library/papers/10655247 | PubMed |
| 12 | 17924447 | Role of alphavbeta6 integrin in acute biliary fibrosis. | Hepatology | 2007 | https://conductscience.org/library/papers/17924447 | PubMed |
| 13 | 1846424 | An antibody to neutrophils attenuates alpha-naphthylisothiocyanate-induced liver injury. | J Pharmacol Exp Ther | 1991 | https://conductscience.org/library/papers/1846424 | PubMed |
| 14 | 18221819 | Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies. | J Hepatol | 2008 | https://conductscience.org/library/papers/18221819 | PubMed |
| 15 | 16015684 | Comparison of murine cirrhosis models induced by hepatotoxin administration and common bile duct ligation. | World J Gastroenterol | 2005 | https://conductscience.org/library/papers/16015684 | PubMed |
| 16 | 24633426 | The antifibrinolytic drug tranexamic acid reduces liver injury and fibrosis in a mouse model of chronic bile duct injury. | J Pharmacol Exp Ther | 2014 | https://conductscience.org/library/papers/24633426 | PubMed |
| 17 | 10025398 | The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. | Cell | 1999 | https://conductscience.org/library/papers/10025398 | PubMed |
| 18 | 23855292 | Vascular biology of the biliary epithelium. | J Gastroenterol Hepatol | 2013 | https://conductscience.org/library/papers/23855292 | PubMed |
| 19 | 19554543 | Primary biliary cirrhosis. | Hepatology | 2009 | https://conductscience.org/library/papers/19554543 | PubMed |
| 20 | 9780343 | Molecular pathogenesis of cholestasis. | N Engl J Med | 1998 | https://conductscience.org/library/papers/9780343 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33918904 | Pathological Study of Facial Eczema (Pithomycotoxicosis) in Sheep. | Animals (Basel) | 2021 | https://conductscience.org/library/papers/33918904 | PubMed |
| 33792809 | Suppression of systemic inflammation and signs of acute and chronic cholangitis by multi-kinase inhibitor 1-(4-Cl-benzyl)-3-chloro-4-(CF3-phenylamino)-1H-pyrrole-2,5-dione. | Mol Cell Biochem | 2021 | https://conductscience.org/library/papers/33792809 | PubMed |
| 31579944 | Genetic or pharmacologic blockade of enhancer of zeste homolog 2 inhibits the progression of peritoneal fibrosis. | J Pathol | 2020 | https://conductscience.org/library/papers/31579944 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALPL | 249 | PubTator's text mining | https://conductscience.org/library/genes/249 | NCBI Gene |
| COL1A1 | 1277 | PubTator's text mining | https://conductscience.org/library/genes/1277 | NCBI Gene |
| ITGB6 | 3694 | PubTator's text mining | https://conductscience.org/library/genes/3694 | NCBI Gene |
| RAG1 | 5896 | PubTator's text mining | https://conductscience.org/library/genes/5896 | NCBI Gene |
| TGFB2 | 7042 | PubTator's text mining | https://conductscience.org/library/genes/7042 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28049044
GET https://conductscience.org/api/papers/v1/28049044/references?page=2